The following browsers support numerous web standards including CSS,XHTML, and the DOM (a universal means of controlling the behavior of web pages):
Please note that this is not intended be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.

Member, St. Jude Faculty
Director, Bone Marrow Transplantation and Cellular Therapy
Oncology
Bone Marrow Transplantation & Cellular Therapy
Wing Leung, MD, PhD
Bone Marrow Transplantation & Cellular Therapy
MS 260, Room C-6071
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
MD - University of Hong Kong
PhD - Johns Hopkins University
Leung W, Ahn H, Rose SR, Phipps S, Smith T, Gan K, O'connor M, Hale GA, Kasow KA, Barfield RC, Madden RM, Pui CH. A Prospective Cohort Study of Late Sequelae of Pediatric Allogeneic Hematopoietic Stem Cell Transplantation. Medicine 86(4):215-224, 2007.
Leung W, Handgretinger R, Iyengar R, Turner V, Holladay MS, Hale GA. Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma. Br J Cancer 97(4):539-542, 2007.
Leung W, Iyengar R, Triplett B, Turner V, Behm FG, Holladay MS, Houston J, Handgretinger R. Comparison of killer Ig-Like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol 174(10): 6540-6545, 2005.
Leung W, Iyengar R, Leimig T, Holladay MS, Houston J, Handgretinger R. Phenotype and function of human natural killer cells purified by using a clinical-scale immunomagnetic method. Cancer Immunol Immunother 54(4):389-394, 2005.
Leung W, Iyengar R, Turner V, Lang P, Bader P, Conn P, Niethammer D, Handgretinger R. Determinants of antileukemia effects of allogeneic NK cells. J Immunol 172(1):644-650, 2004.
Leung W, Rose SR, Zhou Y, Hancock ML, Burstein S, Schriock EA, Lustig R, Danish RK, Evans WE, Hudson MM, Pui CH. Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 20(13):2959-2964, 2002.
Leung W, Sandlund JT, Hudson MM, Zhou Y, Hancock ML, Zhu Y, Ribeiro RC, Rubnitz JE, Kun LE, Razzouk B, Evans WE, Pui CH. Second malignancy after treatment of childhood non-Hodgkin lymphoma. Cancer 92(7):1959-1966, 2001.
Leung W, Pitts N, Burnette K, Cunningham JM, Horwitz EM, Benaim E, Hale GA, Woodard P, Pui CH, Bowman LC. Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome. Bone Marrow Transplant 27:717-722, 2001.
Leung W, Turner V, Richardson S, Horwitz EM, Benaim E, Hale GA, Woodard P, Bowman LC. Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donors. Hum Immunol 62:3 99-407, 2001.
Leung W, Ribeiro RC, Hudson M, Tong X, Srivastava DK, Rubnitz JE, Sandlund JT, Razzouk BI, Evans WE, Pui CH. Second malignancy after treatment of childhood acute myeloid leukemia. Leukemia 15:41-45, 2001.
Leung W, Hudson MM, Strickland DK, Phipps S, Srivastava DK, Ribeiro RC, Rubnitz JE, Sandlund JT, Kun LE, Bowman LC, Razzouk BI, Mathew P, Shearer P, Evans WE, Pui CH. Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol 18:3273-3279, 2000.
Leung W, Hudson M, Zhu Y, Rivera GK, Ribeiro RC, Sandlund JT, Bowman LC, Evans WE, Kun L, Pui CH. Late effects in survivors of infant leukemia. Leukemia 14:1185-1190, 2000.
Leung W, Ramirez M, Mukherjee G, Perlman EJ, Civin CI. Comparisons of alloreactive potential of clinical hematopoietic grafts. Transplantation 68:628-635, 1999.
Leung W, Ramirez M, Civin CI. Quantity and quality of engrafting cells in cord blood and autologous mobilized peripheral blood. BioI Blood Marrow Transplant 5(2):69-76, 1999.
Leung W, Blakemore K, Jones RJ, Moser HW, Griffin CA, Mukherjee G, Civin CI. A human /murine chimera model for in utero human hematopoietic stem cell transplantation. BioI Blood Marrow Transplant 5(1):1-7, 1999.
Leung W, Columbani P, Lau H, Schwarz K, Friedman A. Long term complete remission and immune tolerance after intensive chemotherapy for lymphoproliferative disorder complicating liver transplant. Transplantation 67(11):1487-1489, 1999.
Leung W, Chen AR, Klann RC, Moss TJ, Davis JM, Noga SJ, Cohen KJ, Friedman AD, Small D, Schwartz CL, Borowitz MJ, Wharam MD, Paidas CN, Long CA, Karandish S, McMannis JD, Kastan MB, Civin CI. Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplant 22(10):971-979, 1998.
Leung W, Ramirez M, Novelli EM, Civin CI. In vivo engraftment potential of clinical hematopoietic grafts. J Invest Med 46(6):303-311, 1998.
Last update: June 2009